UBS AM’s iShares Biotechnology ETF IBB Stock Holding History

UBS AM’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.23M	Sell	6,448 -41	-0.6%	-$7.05K	﹤0.01%	2277
2026 Q1	$1.1M	Buy	6,489 +6,174	+1,960%	+$1.06M	﹤0.01%	2311
2025 Q4	$53.2K	Buy	+315	New	+$51.2K	﹤0.01%	2609
2024 Q4	–	Sell	-20,200	Closed	-$2.94M	–	2704
2024 Q3	$2.94M	Buy	+20,200	New	+$2.92M	﹤0.01%	1830
2019 Q4	–	Sell	-67	Closed	-$6.67K	–	2654
2019 Q3	$6.67K	Sell	67 -4	-6%	-$419	﹤0.01%	2825
2019 Q2	$7.75K	Hold	71	–	–	﹤0.01%	2786
2019 Q1	$7.94K	Hold	71	–	–	﹤0.01%	2711
2018 Q4	$6.85K	Sell	71 -386	-84%	-$41K	﹤0.01%	2687
2018 Q3	$55.7K	Buy	+457	New	+$53.8K	﹤0.01%	2562
2018 Q1	–	Sell	-600	Closed	-$64.1K	–	2661
2017 Q4	$64.1K	Buy	+600	New	+$64.1K	﹤0.01%	2424

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

UBS AM's IBB Position: Q2 2026 in Review

UBS AM reduced its iShares Biotechnology ETF (IBB) stake by 0.63% in Q2 2026, selling an estimated $7.05K and leaving 6,448 shares worth $1.23M. The position accounts for ﹤0.01% of the portfolio, ranked #2277.

UBS AM first reported a position in IBB in Q4 2017 and has held it in 10 quarters since. The position peaked at $2.94M in Q3 2024. 956 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

UBS AM held 6,448 shares of iShares Biotechnology ETF worth $1.23M as of Q2 2026.
UBS AM sold 41 iShares Biotechnology ETF shares in Q2 2026, an estimated $7.05K.
iShares Biotechnology ETF made up ﹤0.01% of UBS AM's portfolio in Q2 2026, its #2277 holding.
UBS AM first reported a position in iShares Biotechnology ETF in Q4 2017 and has held it in 10 quarters since.
UBS AM's iShares Biotechnology ETF position peaked at $2.94M in Q3 2024.
956 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.